Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 3Burkitt Lymphoma 3Neuroblastoma 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Biphenotypic, Acute 2Leukemia 2Ganglioneuroblastoma 2Smoldering Multiple Myeloma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Juvenile 1Immunoglobulin Light-chain Amyloidosis 1Hemoglobinuria, Paroxysmal 1Hemoglobinuria 1Breast Neoplasms 1

Interventions

Vincristine 3Cyclophosphamide 3Cisplatin 3Thiotepa 2Radiotherapy 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Carboplatin 2merphos 1Temozolomide 1Stem Cell Transplantation 1Radiotherapy, Conformal 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Leucovorin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Rhabdoid Tumor × Stem Cell Transplantation × Clear all
NCT00653068 2024-04-23

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

Children's Oncology Group

Phase 3 Completed
70 enrolled 12 charts

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡